Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
Clinical trial NCT02680951 · WITHDRAWN
Trial details
- NCT number
- NCT02680951
- Sponsor
- Emory University
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.